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Abstract Bcl-2 antagonizes apoptosis through mechanisms
which are not completely understood. We have proposed that
apoptosis is initiated by minor lysosomal destabilization followed
some time later by secondary massive lysosomal rupture. In J774
cells over-expressing Bcl-2, early oxidant-induced lysosomal
destabilization is unaffected but secondary lysosomal rupture and
apoptosis are suppressed, despite the fact that wild-type and Bcl-
2 over-expressing cells degrade hydrogen peroxide at similar
rates. It may be that Bcl-2 directly blocks the effects of released
lysosomal enzymes and/or prevents downstream activation of
unknown cytosolic pro-enzymes by released lysosomal hydro-
lases, suggesting a new and heretofore unknown activity of
Bcl-2. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Bcl-2 suppresses cellular apoptosis engendered by oxidants
and other agonists but the mechanisms of Bcl-2 action are not
¢rmly established. Bcl-2 is associated with mitochondrial and
other intracellular membranes [1^4] and belongs to a super-
family of mammalian protein homologs of the Caenorhabditis
elegans ‘Ced-9’ proteins which also are involved in the control
of programmed cell death [5]. Some earlier work suggests that,
under oxidative stress, iron-catalyzed oxidation within the ly-
sosomal compartment leads to lysosomal leak and rupture
[6^9]. Minor lysosomal destabilization of this sort will trigger
reparative autophagocytosis and restoration of normal cellu-
lar function. However, more marked lysosomal leakage and
rupture is associated with apoptotic and, in extremis, necrotic
cell death [7,10^17].
Interestingly, early and minor lysosomal leak caused by
oxidative stress will cause further lysosomal destabilization
and, ultimately, apoptosis which occurs long after removal
of the oxidant stress [15,17^19]. The intimate involvement of
lysosomal leakage in apoptosis is emphasized by the ¢nding
that the release of mitochondrial cytochrome c, generally con-
sidered to be an important distal event in the occurrence of
apoptosis, occurs secondary to this lysosomal destabilization
[20,21]. Therefore, the release of lysosomal hydrolytic enzymes
into the cytosol may be a key event, leading to proteolytic
activation of pro-caspases [13,17] and/or other cytosolic lytic
pro-enzymes. These early events then might lead to further
lysosomal destabilization and direct attack on mitochondria,
with consequent cytochrome c release. This scenario would be
consistent with the aforementioned progressive lysosomal rup-
ture occurring long after removal of the oxidant stress.
We have therefore sought to determine whether Bcl-2 might
somehow act to interrupt this sequence of events. Surpris-
ingly, in J774 cells over-expressing Bcl-2, the early iron-cata-
lyzed lysosomal destabilization caused by oxidants is unaf-
fected. However, Bcl-2 over-expression e¡ectively prevents
the later lysosomal destabilization and, expectably, apoptosis.
These ¢ndings raise the possibility that Bcl-2 somehow blocks
downstream events that result in the later phase of lysosomal
rupture, and that this activity may be involved in the still
mysterious mode of action of this anti-apoptotic protein.
2. Materials and methods
2.1. Materials
Chemicals were purchased from Sigma (St. Louis, MO, USA) un-
less otherwise indicated. RPMI 1640 medium, fetal bovine serum,
glutamine, penicillin and streptomycin were obtained from Gibco
BRL (Grand Island, NY, USA). The polyclonal antibodies against
Bcl-2 (sc-783) and monoclonal antibody against L-actin (sc-8432)
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA), while
the enhanced chemiluminescence Western blotting reagents were ob-
tained from Amersham Pharmacia Biotech (Stockholm, Sweden). The
CaspACE FITC-VAD-FMK In Situ Marker0 was purchased from
Promega Biosciences (San Luis Obispo, CA, USA). DOTAP was
from Boehringer Mannheim (Indianapolis, IN, USA).
2.2. Cell cultures
J774 cells (a murine histiocytic lymphoma cell line) were maintained
in RPMI 1640 medium supplemented with 10% fetal bovine serum,
2 mM glutamine, 50 U/ml penicillin, 50 Wg/ml streptomycin and 1%
non-essential amino acids. Cells were maintained in plastic £asks and
subcultivated at con£uence twice a week. Medium was changed daily.
For experiments, cells were transferred into 35 mm six -well plates
(5U105 cells/well) 24 h before use.
2.3. Transfection assays
J774 cells were subcultivated and grown in six-well plates (5U105
cells/well) as described above. The cells were transfected with mBCL-
2K/pMKITNeo expression plasmids [22], which contain a neomycin
resistance element, using liposomal delivery by DOTAP according to
the manufacturer’s directions. Ten clones of stably transfected cells
were selected by neomycin resistance, and their expression levels of
Bcl-2 were assayed by Western blot analysis (vide infra). Compared to
the wild-type J774 cells, three clones of the transfected cells had a ¢ve-
fold increase of immunoreactive Bcl-2 protein. These clones were ex-
panded, mixed and used for experiments. The Bcl-2 over-expressing
J774 cell line hereafter is termed ‘J774-Bcl-2’.
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2.4. Western blot analysis
Approximately 106 J774 and J774-Bcl-2 were lysed in a bu¡er con-
taining 20 mM Tris^HCl, 120 mM NaCl, 10% glycerol, 1 mM
Na3VO4, 2 mM EDTA, 1% Triton X-100 and 1 mM phenylmethyl-
sulfonyl £uoride, pH 7.5. Whole cell lysates were separated on 12%
SDS^PAGE gels and transferred onto an Immobilon0 membrane for
2 h at 200 mA and 4‡C. Filters then were incubated at room temper-
ature for 1 h in blocking bu¡er (5% low-fat milk powder in Tris-
bu¡ered saline (TBS)) and for another 2 h in dilution bu¡er (0.5%
low-fat milk powder in TBS) containing a 1:500 dilution of the poly-
clonal anti-Bcl-2 antibodies, or a 1:1000 dilution of the monoclonal
antibody against L-actin. After washing in TBS with 0.06% Tween 20,
Immobilon membranes were incubated for 1 h at room temperature in
a bu¡er containing a 1:1500 dilution of the peroxidase-conjugated
secondary antibody. After washing, peroxidase-dependent chemilumi-
nescence was detected employing enhanced chemiluminescence West-
ern blotting reagents and hyper¢lm according to the manufacturer’s
instructions.
2.5. Hydrogen peroxide assay
Hydrogen peroxide (H2O2) concentration was assayed as described
previously [23]. Brie£y, 50 Wl of sample was reacted with 3 ml K-
hydroxylphenylacetic acid (40 WM) and horseradish peroxidase (5.0
U/ml) in bu¡er (0.1 M KPO4, pH 7.4) for 5 min at 37‡C. Then the
system was incubated at room temperature for an additional 5 min.
The £uorescent product was measured using a Shimadzu RF-540
spectro£uorophotometer with excitation at 315 nm and emission at
410 nm.
2.6. Pretreatment of cells with desferrioxamine (Des)
In some experiments, J774 cells were pre-treated with Des for 1 h
under otherwise normal culture conditions by exposure to pre-warmed
(37‡C) complete medium containing 1 mM Des (¢nal concentration).
The cells then were incubated under standard culture conditions
(without Des) for another 30 min and, ¢nally, exposed to H2O2 as
described below.
2.7. Exposure to H2O2
Wild-type J774 cells and J774-Bcl-2 cells (5U105 in 2 ml of com-
plete medium), cultured in six-well plates as described above, were
exposed for 1 h at 37‡C to a steady-state concentration (40 WM) of
H2O2 as described previously [24]. To abruptly obtain this steady-
state concentration of H2O2, 1.5 Wg/ml glucose oxidase was added
together with H2O2 in an amount to give 45 WM. Following 1 h
incubation, under otherwise standard culture conditions, catalase
was added to clear the H2O2. The cells were then quickly rinsed
with sterile phosphate-bu¡ered saline (PBS), and fresh complete me-
dium was added.
2.8. Lysosomal stability assessment
Cells were assessed for lysosomal stability using the acridine orange
(AO) uptake and relocation methods [25]. AO is a lysosomotropic
base and a metachromatic £uorochrome exhibiting red £uorescence
when highly concentrated (as is the case in intact lysosomes where AO
is retained in its charged, AOH, form) and green £uorescence at low
concentration (as is the case when some lysosomes have ruptured and
AO relocates to the cytosol where it occurs predominantly in the
deprotonated form). The number of remaining intact lysosomes may
be evaluated by assaying red £uorescence (AO uptake method) fol-
lowing AO staining of the cells after exposure to oxidative stress.
Because of the much higher sensitivity of the photomultiplier to green
than to red photons, this method is far less sensitive than following
AO relocation within cells stained with AO before oxidant exposure
(AO relocation method). In order to detect early and minor lysosomal
destabilization, we therefore used the AO relocation method, while
the AO uptake method was used to assay later and more pronounced
lysosomal rupture.
In all AO experiments, AO £uorescence was measured by £ow cy-
tometry using a Becton-Dickinson FACScan (Becton-Dickinson,
Mountain View, CA, USA) equipped with a 488 nm argon laser. In
AO uptake experiments, following oxidant exposure cells within in-
dividual wells (5U105) were brie£y stained with 5 Wg/ml AO for 15
min under otherwise standard culture conditions and then rinsed in
complete medium (U2). The cells then were detached by scraping with
a rubber policeman and collected for £ow cytometric assessment of
red (uptake, FL3 channel) or green (relocation, FL1 channel) AO
£uorescence. In the case of relocation studies, AO staining was
done before exposure (5^60 min) to oxidative stress, whereas uptake
studies were done on cells which ¢rst were exposed to 60 min of
oxidative stress, returned to standard culture conditions for up to
12 h and then brie£y stained with AO as described above. CellQuest
software was used to analyze the data.
2.9. Apoptosis assessment assay
The DNA fragmentation (Nicoletti) assay is based on propidium
iodide staining of nuclear DNA and was performed essentially as
described elsewhere [26]. Brie£y, the cell pellets from individual wells,
prepared as described above, were gently resuspended in 1.5 ml of a
hypotonic and membrane-disrupting solution of propidium iodide (50
Wg/ml in 0.1% sodium citrate with 0.1% Triton X-100) in 12U75 mm
polypropylene tubes. The tubes were kept at 4‡C in the dark overnight
before the £ow-cytometric analyses. The propidium iodide-induced
red £uorescence of suspended individual nuclei was measured using
the FL3 channel for red £uorescence.
Apoptosis also was evaluated by microscopical analysis of living
cells, initially stained according to the manufacturer’s directions
with a FITC-conjugated broad spectrum inhibitor of caspases, Casp-
ACE1 FITC-VAD-FMK In Situ Marker0, that irreversibly binds to
activated caspases. Brie£y, J774 cells were seeded at 5U105 cells/ml,
exposed to H2O2 as described above, and then incubated under stan-
dard culture conditions for another 4 h. The marker was added to the
medium at a ¢nal concentration of 10 WM. The cells then were in-
cubated in the dark for 20 min, rinsed three times in PBS (5 min in
total), and observed, counted and photographed using a Nikon £uo-
rescence microscope.
2.10. Statistical analysis
All experiments were repeated three times. The values are given as
arithmetic means þ S.D. Statistical signi¢cance was determined using
Fig. 1. Bcl-2 over-expression in J774 cells and lack of e¡ect of that
over-expression on hydrogen peroxide degradation. A: Western
blots for Bcl-2 re£ecting a ¢ve-fold increase for the transfected cells.
L-actin was used as a loading control. B: Wild-type and Bcl-2 over-
expressing J774 (106) cells were exposed to a bolus dose of H2O2
and residual H2O2 was measured at the indicated times. Each point
represents the mean þ S.D. of triplicate determinations.
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Student’s two-tailed t-test. A P-value 9 0.05 was considered signi¢-
cant.
3. Results
The relative levels of Bcl-2 expression by J774 and J774-Bcl-
2 cells are shown in Fig. 1A, with actin used as a loading
control. To ensure that any di¡erences between wild-type
and Bcl-2 over-expressing cells observed in response to
H2O2 were not due to changes in H2O2 catabolism, we mea-
sured H2O2 clearance following the addition of a bolus dose
of 100 WM H2O2 to 106 cells. As shown in Fig. 1B, clearance
of H2O2 by J774 cells was una¡ected by Bcl-2 over expression.
This excludes the possibility that the Bcl-2 transfected cells
had somehow gained an enhanced capacity to degrade H2O2
(for example by up-regulating catalase and/or glutathione per-
oxidase).
During the initial 5^15 min of exposure of the cells to
steady-state 40 WM H2O2, there was no signi¢cant di¡erence
between wild-type and Bcl-2 transfected cells with respect to
early lysosomal rupture (as assayed by an increase in cytosolic
green £uorescence secondary to the leak of AO from damaged
lysosomes). However, distinct di¡erences were noted with re-
spect to later lysosomal rupture at 30 and 60 min (Fig. 2) and
at 8^12 h when lysosomal rupture was assayed by the num-
bers of ‘pale’ cells (having reduced numbers of intact lyso-
somes) (Fig. 3A,B). The lysosomes of cells pre-exposed to
the potent iron chelator, Des, were completely stabilized
(Fig. 2). Des appears to enter cells largely by endocytosis
and, thus, ends up almost exclusively in the lysosomal com-
partment [27^30], suggesting that intra-lysosomal iron-cata-
lyzed oxidative reactions may be an important factor in oxi-
dative lysosomal destabilization. The similarity between wild-
type and J774-Bcl-2 during the early phases of oxidative stress
suggests that Bcl-2 ^ unlike Des ^ is not protecting against
early iron-catalyzed intra-lysosomal oxidation, but rather
against some secondary event(s) which leads to later lysoso-
mal destabilization and rupture.
When the frequency of apoptosis was assessed 12 h after
exposure to oxidative stress (Fig. 4), the number of apoptotic
cells corresponded closely to the number of ‘pale’ cells. It
should be pointed out (see Fig. 3A) that some ‘pale’ cells
have lost few lysosomes, while others are almost devoid of
these organelles. The latter cells probably are post-apoptotic
necrotic. Roughly twice as many wild-type J774 cells were
apoptotic/post apoptotic compared to the J774-Bcl-2.
4. Discussion
Oxidative stress-induced apoptosis is suppressed by over-
expression of the anti-apoptotic protein, Bcl-2, but the mech-
anisms involved are not well understood [1,31,32]. The Bcl-2
Fig. 2. Lysosomal rupture is lessened at 30^60 min of hydrogen per-
oxide exposure in J774 cells over-expressing Bcl-2. Wild-type and
Bcl-2 over-expressing cells were pre-stained with AO as described in
Section 2 and then exposed to a steady-state concentration of H2O2
for the indicated periods of time. In some experiments, J774 cells
were pre-treated with 1 mM Des. Green AO-induced £uorescence
was analyzed as described in Section 2. The results are presented as
percentage of values before initiation of oxidative stress. Each point
represents the mean þ S.D. of triplicate determinations. All points
for the Des-curve are statistically di¡erent (P6 0.01) from each of
those for the J774 and J774-Bcl-2, while only the time points be-
yond 15 min di¡er between J774 and J774-Bcl-2 (P6 0.01).
Fig. 3. Bcl-2 over-expressing J774 cells exhibit enhanced lysosomal
stability 12 h after oxidant exposure. Wild-type and Bcl-2 over-ex-
pressing cells were exposed to a steady-state concentration of H2O2
for 1 h. Cells then were returned to normal culture conditions for
the indicated periods of time, AO stained and assayed for red £uo-
rescence as described in Section 2. A: Flow cyto£uorometric analy-
sis of the percentage of ‘pale’ cells (i.e. de¢cient in intact lysosomes)
following 1 h of exposure to oxidative stress and another 12 h
under normal culture conditions. B: Quantitation of the results
shown in A. Each point represents the mean þ S.D. of triplicate de-
terminations. All values shown in A and B for oxidative stress-ex-
posed J774 vs J774-Bcl-2 (except ‘0’ time) are signi¢cantly di¡erent
(P6 0.001), while there are no di¡erences between the unexposed
cells.
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family presently consists of the anti-apoptotic proteins Bcl-2
and Bcl-XL, but also contains pro-apoptotic proteins such as
Bax, Bik and Bak [33,34]. Bcl-2 is active as an anti-apoptotic
protein only in its phosphorylated form and when dimerized
or complexed with Bcl-XL. Thus, it is activated by protein
kinase C and inactivated by protein phosphatase 2 or when
complexed with Bax, Bik or Bad [22,35^40]. It has been sug-
gested that Bcl-2 might act either as an anti-oxidant [41] and/
or a regulator of so-called mitochondrial permeability transi-
tion pores [5,42^44]. In the latter case, Bcl-2 might suppress
the release of apoptosis-inducing cytochrome c, perhaps by
controlling ion £uxes between cellular compartments.
The ¢ndings of the present study may suggest a completely
new function for Bcl-2, namely prevention of the labilization
of lysosomes that occurs secondary to oxidant interactions
with intra-lysosomal iron. As indicated by the present results,
and the hypothetical scheme shown in Fig. 5, early oxidative
lysosomal rupture appears to lead to the eventual release of
lysosomal hydrolytic enzymes. These destructive enzymes may
then be su⁄cient to induce apoptosis, either by direct activa-
tion of pro-caspases or by attack on mitochondrial and lyso-
somal membranes, resulting in release of pro-apoptotic cyto-
chrome c and more lysosomal enzymes. Alternatively, it may
be that these lysosomal hydrolytic enzymes activate as-yet
unde¢ned cytosolic factors which, in turn, attack both lyso-
somes and mitochondria, causing apoptosis by further en-
hancement of lysosomal and/or mitochondrial permeability.
Of possible relevance to our observations are scattered ear-
lier reports suggesting a link between the activation of phos-
pholipase A2 and apoptosis [45,46]. Furthermore, inhibitors
of cytosolic phospholipases (A2 and C) have been shown to
prevent apoptotic cell death [46,47], raising the intriguing pos-
sibility that Bcl-2 might act, directly or indirectly, to prevent
Fig. 5. The lysosomal-mitochondrial axis theory of oxidative stress-induced apoptosis. Intralysosomal, iron-catalyzed oxidation leads to oxida-
tive lysosomal rupture secondary to production of hydroxyl radicals. Some released lysosomal enzymes (LE) may activate pro-caspases as well
other cytosolic pro-enzymes. Together, these may attack mitochondrial and lysosomal membranes, causing release to the cytosol of cytochrome
c and of additional LE. Bcl-2 may block the later stages, perhaps by acting at indicated (*) steps, although not the ¢rst phase of LE release.
Fig. 4. Bcl-2 over-expressing J774 cells are less susceptible than wild-
type cells to oxidative stress-induced apoptosis. Wild-type and Bcl-2
over-expressing cells were exposed to a steady-state concentration of
H2O2 for 1 h and then returned to normal culture conditions for an-
other 12 h. The cells were then (A) stained with CaspACE1 FITC-
VAD-FMK In Situ Marker0 or (B) assayed for apoptosis by the
Nicoletti assay as described in Section 2. Results shown in (B) repre-
sent the mean þ S.D. of triplicate determinations. The di¡erence be-
tween J774+H2O2 and J774-Bcl-2+H2O2 is signi¢cant at P6 0.001.
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phospholipase-mediated destabilization of lysosomal and mi-
tochondrial membranes. Regardless of whether this specula-
tion is correct, it is clear from the present results that Bcl-2
suppresses delayed lysosomal rupture and that this is associ-
ated with protection of cells against apoptotic cell death fol-
lowing exposure to low dose oxidant stress. Inasmuch as Bcl-2
over expression does not a¡ect the ability of cells to catabolize
H2O2, these results suggest a novel, but presently unde¢ned,
anti-apoptotic function of Bcl-2.
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